Generate a tailored SOP for Dr. Stanley Liauw. Improve your application with a focused, well-structured draft.
Dr. Stanley Liauw serves as the Director of Clinical Operations and is the clinical lead for the genitourinary (GU) and gastrointestinal (GI) cancer programs in the Department of Radiation and Cellular Oncology at the University of Chicago. For over 10 years, he has developed research programs focused on clinical outcomes and trials, aiming to define current clinical outcomes and test novel regimens to reduce the morbidity and mortality associated with radiation therapy for cancer treatment. His principal efforts include analyzing and reporting cancer outcomes from radiation therapy, utilizing data from multiple institutional databases encompassing over 2000 patients, leading to numerous publications in prestigious peer-reviewed journals such as the Journal of Clinical Oncology and the International Journal of Radiation Oncology, Biology, Physics. His research interests include improving the therapeutic ratio of radiation therapy, investigating imaging use in radiation oncology, and exploring potential markers for response to treatment. Dr. Liauw has initiated various clinical protocols and trials, specifically targeting GU and GI cancers and has contributed to multiple phase studies involving innovative treatment methods. He is recognized nationally and internationally for his educational contributions in radiation oncology and serves as an invited lecturer and visiting professor across various institutions.
Department of Philosophy